Raffles Medical Group Ltd Financials

Market Capitalization S$1.56 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	28.00
Forward PE	21.00
Price to Sales TTM	S$2.22
Price to Book MRQ	S$1.54
Enterprise to Revenue	1.95
Enterprise to EBITDA	14.07

Financial Reports as of Dec. 31, 2019

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2019-12-31
Profit Margin	8.67%
Operating Margin	11.29%
Return on Assets TTM	2.99%
Return on Equity TTM	6.02%

Income Statement

Revenue TTM	S$702,969,984
Revenue per Share TTM	S$0.38
Quarterly Revenue Growth	-1.40%
Gross Profit TTM	S$310,884,000
EBITDA	S$109,210,000
Net Income to Common TTM	S$60,942,000
Diluted EPS TTM	S$0.03
Quarterly Earnings Growth YoY	-48.80%

Balance Sheet

Total Cash MRQ	S$316,324,992
Total Cash per Share MRQ	S$0.17
Total Debt MRQ	S$
Total Debt to Equity MRQ	10.60
Current Ratio MRQ	1.20
Book Value per Share MRQ	S$0.55

Cash Flow

Operating Cash Flow TTM	S$97,186,000
Levered Free Cash Flow TTM	S$78,967,872

BSL Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,858,099,968
Float Shares	793,243,301
Avg 10 Volume	610,800
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	59.16%
% Held by Institutions	14.65%

Stock Price Summary

Beta	0.54
Fifty Two Week Low	S$0.83
Fifty Two Week High	S$1.07
Fifty Two Week Change	-20.96%
Day 50 MA	S$0.85
Day 200 MA	S$0.93

Dividends and Splits

Forward Annual Dividend Rate	S$0.05
Forward Annual Dividend Yield	5.75%
Trailing Annual Dividend Rate	S$0.06
Trailing Annual Dividend Yield	7.43%
Payout Ratio	74.07%
Dividend Date
Ex Dividend Date	2024-05-13
Last Split Factor
Last Split Date	2016-05-09